Hi ,

This week’s digest is brought to you by BiomEdit, an innovation company that discovers, designs, and develops novel microbiome-derived products to address unmet needs in animal health.

On-Demand Webinar:

Did you miss our investment report webinar? Want a free copy of our annual Synthetic Biology Investment Report? Not to worry, we got you covered! Click the following link to view the recorded webinar and download the report: 

Who’s Coming to SynBioBeta?

Google X, Amazon, Sony, Amgen, Allonnia, Geltor, Modern Synthesis, SRI International, Matterworks, and more have all recently signed up, and you can meet them all from May 6 to 9 at the San Jose Convention Center.

If you are interested in having a space on the floor, please contact our team here

New SynBioBeta Speakers Announced:

New Sponsors & Exhibitors:

  • AgFunder is a new kind of venture capital firm. Their mission is to invest in bold and impactful technologies to rapidly transform our food and agriculture system.

  • Scientific Bioprocessing, Inc. (sbi) is dedicated to offering cutting-edge solutions for the life science industry, pioneering digitally simplified bioprocessing.

  • Synonym accelerates the world's biological future by developing, financing, and building commercial-scale biomanufacturing facilities.

  • BioP2P Network is a not-for-profit collaborative advancing manufacturing for the US bioeconomy.

  • IFF is an industry leader in food, beverage, health, and biosciences. It creates essential solutions – from global icons to unexpected innovations and experiences.

  • Securecell is pioneering the world's next solutions for global biotech and MedTech systems.

  • Sierra BioSystems is an enterprise founded by biotechnology engineers looking to solve the problems behind the high costs of synthetic DNA.

  • DMC Biotechnologies’ technology platform enables a cost-effective, reliable supply of products that the world needs to build economically sound and environmentally friendly chemical production.

If you are interested in having a space on the exhibit hall floor, please contact Anissa Cooke (

Making a Big Announcement at SynBioBeta this year?

  • 2024 Exhibitors and Sponsors: Take advantage of the opportunity we have to get in front of journalists from outlets like The Economist, Forbes, The New Yorker, Wired, STAT, GEN, GenomeWeb, and many more. The deadline for sending headlines and embargoed news to be included in the 2024 Media Kit is 5 pm MT on Monday, April 1st. Please send to Katie Orrell. (

Register now


  • How Preparing Plants for Space Can Push Synthetic Biology Boundaries on Earth? Plant experiments are routine in the space station, but can synthetic biology push even further the plant science boundaries and provide fresh produce for future missions to the moon or Mars?

  • Is Pharma Finally Catching on to SynBio? The synbio industry has tried to raise awareness of its capabilities to pharma leaders for years. Success has been uneven at best. While modalities like mRNA and cell and gene therapy have grown significantly, the synbio industry as a whole is still under-recognized. Or is it?

Industry News:

Additional Industry News:

  • Absci raises $86M in public stock offering: Absci Corp. (Nasdaq: ABSI), a Vancouver-based AI drug creation company, on Friday announced it had closed a public offering of common stock, raising $86.4 million. (Press release)

  • Synthetic and Engineering Biology British-Swiss Summit: Register now for this event on May 22-23. Fiona Mischel, our Director of Human Health Content and Innovation, will speak at the event!

  • Neobe Therapeutics raises over $2 million for synthetic biology-enabled tumor microenvironment remodeling. (Press release)

  • Breakthrough Could Reduce Cultivated Meat Production Costs by up to 90% (SciTechDaily)

  • How a Microbe From Yellowstone’s Hot Springs Could Help Feed the World: A Chicago startup has turned a fungus found by NASA into a protein-packed food.

  • Protein design pioneer David Baker on why sharing code is key to building biotech startups (GeekWire)

  • Science Creates has launched the second iteration of its equity-free biotech accelerator program, backed by the UK government and a handful of European and US VCs. (UKTN)

  • USPRD: The U.S. National Science Foundation published a new $40 million funding opportunity designed to accelerate the translation of artificial intelligence-based approaches to protein design that will enable new applications of importance to the U.S. bioeconomy. Over the next three years, the Use-Inspired Acceleration of Protein Design (USPRD) initiative seeks to advance protein design and its applications, specifically emphasizing the design of enzymes. Read the funding opportunity to learn more.

  • CFIRE: The U.S. National Science Foundation published a new $40 million funding opportunity designed to accelerate the adoption of cell-free systems, enable new applications of this technology, and contribute to the growth of the U.S. bioeconomy. Over the next three years, the Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications (CFIRE) initiative seeks to reduce the cost, increase the range of cell-free systems, and develop and demonstrate their use. Read the funding opportunity to learn more.



Jeff Buguliskis, PhD

Director of Content, SynBioBeta

Who's hiring?

Email Marketing by ActiveCampaign